Ultragenyx Pharmaceutical Inc. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Option Exercise | A | 48.43 | 7,975 | 386,229 | 7,975 | |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Payment of Exercise | F | 48.43 | 110 | 5,327 | 10,675 | 10.8 K to 10.7 K (-1.02 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Grant | A | 0.00 | 1,313 | 0 | 10,785 | 9.5 K to 10.8 K (+13.86 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Option Exercise | A | 48.43 | 25,000 | 1,210,750 | 25,000 | |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 48.43 | 205 | 9,928 | 15,419 | 15.6 K to 15.4 K (-1.31 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 4,500 | 0 | 15,624 | 11.1 K to 15.6 K (+40.45 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Option Exercise | A | 48.43 | 27,000 | 1,307,610 | 27,000 | |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Payment of Exercise | F | 48.43 | 276 | 13,367 | 16,645 | 16.9 K to 16.6 K (-1.63 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Grant | A | 0.00 | 5,000 | 0 | 16,921 | 11.9 K to 16.9 K (+41.94 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Option Exercise | A | 48.43 | 32,000 | 1,549,760 | 32,000 | |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Payment of Exercise | F | 48.43 | 441 | 21,358 | 22,173 | 22.6 K to 22.2 K (-1.95 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Grant | A | 0.00 | 6,500 | 0 | 22,614 | 16.1 K to 22.6 K (+40.34 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Option Exercise | A | 48.43 | 30,000 | 1,452,900 | 30,000 | |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Payment of Exercise | F | 48.43 | 307 | 14,868 | 82,098 | 82.4 K to 82.1 K (-0.37 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Grant | A | 0.00 | 6,000 | 0 | 82,405 | 76.4 K to 82.4 K (+7.85 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Option Exercise | A | 48.43 | 35,000 | 1,695,050 | 35,000 | |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Payment of Exercise | F | 48.43 | 397 | 19,227 | 62,113 | 62.5 K to 62.1 K (-0.64 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Grant | A | 0.00 | 7,000 | 0 | 62,510 | 55.5 K to 62.5 K (+12.61 %) |